Insulin aspart, recombinant Subcutaneous and Palonosetron injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Palonosetron injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: palonosetron
Brand name: Aloxi
Synonyms: Palonosetron (injection), Palonosetron
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Palonosetron Intravenous
- Insulin aspart, recombinant Subcutaneous-Palynziq
- Insulin aspart, recombinant Subcutaneous-Pamabrom
- Insulin aspart, recombinant Subcutaneous-Pamelor
- Insulin aspart, recombinant Subcutaneous-Pamidronate
- Insulin aspart, recombinant Subcutaneous-Pamidronate Disodium
- Palonosetron injection-Insulin degludec
- Palonosetron injection-Insulin Degludec (U-100) Prefilled Pens
- Palonosetron injection-Insulin Degludec (U-100) Vials
- Palonosetron injection-Insulin Degludec (U-200) Prefilled Pens
- Palonosetron injection-Insulin degludec and liraglutide
- Palonosetron injection-Insulin degludec and liraglutide Subcutaneous